Indonesian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
antioxidant/kanker
Tautan disimpan ke clipboard
Halaman 1 dari 158 hasil
Mitochondria targeted cationic anti-oxidant compounds for prevention, therapy or treatment of hyper-proliferative disease, neoplasias and cancers
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
PRIORITY STATEMENT
This application claims benefit of priority as applicable under 35 U.S.C. .sctn.120 as a continuation of PCT/US2008/056035, filed Mar. 6, 2008, which claims benefit under 35 U.S.C. .sctn.119(e) of U.S. Provisional Application No. 60/905,237, filed Mar. 6, 2007.
FIELD OF THE
Conveniently injectable or implantable sustained-release antioxidant formulations for therapies of ocular maladies or cancer
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
The present invention provides for novel liquid and solid, sustained release formulations of antioxidants for intraocular and intratumoral injection or implantation as novel methods of treatment of ocular afflictions and tumors/cancer.
BACKGROUND
In Earth's oxygen rich
Use of antioxidants as an adjuvant to immune stimulators to augment tumor immunity and prevent toxicity associated with oxidative stress
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
TECHNICAL FIELD
This application relates to the area of anticancer therapeutics, more specifically, the application relates to the area of cancer immunotherapy. Specifically, the application discloses means of decreasing toxicity associated with immunotherapeutic interventions, while concurrently
Synthesis and uses of new ascorbic acid derivatives which have anti-oxidant and anti-cancer activities
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to new hydrophobic ascorbic ester compounds, which are synthesized by linking ascorbic acid either wit monomer prostaglandin B.sub.2 or with oligomeric derivatives of prostaglandin B.sub.2, as well as to methods of
Method for producing antioxidant and prevention of cancer
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION
A pharmaceutical composition for prevention and treatment of cancer, cardiovascular disease and antioxidation contains resveratol. The new method of process for producing resveratol is extracted resveratol from oil residue and stems of peanuts or stems of other cheap
Prophylactic therapeutic and industrial antioxidant compositions enhanced with stabilized atomic hydrogen/free electrons and methods to prepare and use such compositions
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND OF THE INVENTION
1. Field of the Invention
The invention provides prophylactic, therapeutic and industrial antioxidant compositions that are enhanced with stabilized atomic hydrogen/free electrons. The invention also provides methods to prepare and use such antioxidant compositions.
2.
Composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
CROSS REFERENCE TO RELATED APPLICATION
This application is a national stage of international application No. PCT/JP2009/050020 filed on Jan. 6, 2009, which also claims priority under 35 USC 119 to Japanese Patent Application No. 2008-001801 filed Jan. 9, 2008, the entire content of which are
Anti-oxidative tricyclic, condensed heterocyclic compound
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
This application is a 371 of PCT/JP95/01975 filed Sep. 28, 1995.
TECHNICAL FIELD OF THE INVENTION
The present invention relates to a novel tricyclic, condensed heterocyclic compound. The novel tricyclic, condensed heterocyclic compound in accordance with the present invention is a useful substance
Method of treating tumour cells using catalase
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
The present invention relates to the use of antioxidants to treat tumour cells; to pharmaceutical compositions containing antioxidants adapted for such use; and, to methods for the treatment of tumour cells by administering antioxidants.
BACKGROUND OF THE INVENTION
Ionizing
Method of treating tumour cells using catalase
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
The present invention relates to the use of antioxidants to treat tumour cells; to pharmaceutical compositions containing antioxidants adapted for such use; and, to methods for the treatment of tumour cell by administering antioxidants.
BACKGROUND OF THE INVENTION
Ionizing
Uses of hydroquinone substituted polyunsaturated fatty acids as antioxidants
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT
Not applicable
REFERENCE TO A "MICROFICHE APPENDIX"
Not applicable
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to hydroquinone substituted polyunsaturated fatty acids. More particularly, the
Synergistic antioxidant combination of delta tocols and polyphenols
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
FIELD OF THE INVENTION
The present invention relates to compositions comprising a combination of at least one source of .delta.-tocols (tocotrienol and/or tocopherol), with an antioxidant source comprising polyphenolic compounds. Due to synergistic effects, such compositions are useful in treating
Natural organic tanning sunscreen compositions and methods of treatment, to reduce the risk of skin cancer caused by sunlight and ultraviolet radiation (UVA and UVB)
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
BACKGROUND FIELD OF THE INVENTION
A Natural organic sunscreen composition for external application which contains natural organic medicinal properties, (The term "organic" as used herein refers to the fact that no heat or chemical substances have been added to the natural sunscreen
Tert-butyl derivatives of benzylidenecamphor, process for preparing them, their use as antioxidant agents and cosmetic and pharmaceutical compositions containing them
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
The present invention relates to new tert-butyl derivatives of benzylidenecamphor, to a process for preparing them and to their uses as antioxidant agents as well as in cosmetic compositions for daily use or for protection against sunlight and in pharmaceutical compositions for the preventive
Tert-butyl derivatives of benzylidenecamphor, process for preparing them, their use as antioxidant agents and cosmetic and pharmaceutical compositions containing them
Hanya pengguna terdaftar yang dapat menerjemahkan artikel
Masuk daftar
The present invention relates to new tert-butyl derivatives of benzylidenecamphor, to a process for preparing them and to their uses as antioxidant agents as well as in cosmetic compositions for daily use or for protection against sunlight and in pharmaceutical compositions for the preventive
Database tanaman obat terlengkap yang didukung oleh sains
- Bekerja dalam 55 bahasa
- Pengobatan herbal didukung oleh sains
- Pengenalan herbal melalui gambar
- Peta GPS interaktif - beri tag herba di lokasi (segera hadir)
- Baca publikasi ilmiah yang terkait dengan pencarian Anda
- Cari tanaman obat berdasarkan efeknya
- Atur minat Anda dan ikuti perkembangan berita, uji klinis, dan paten
Ketikkan gejala atau penyakit dan baca tentang jamu yang mungkin membantu, ketik jamu dan lihat penyakit dan gejala yang digunakan untuk melawannya.
* Semua informasi didasarkan pada penelitian ilmiah yang dipublikasikan
